Novel Therapies Mild Moderate Atopic Dermatitis

Patient dosing begins for Phase 2 study of new topical gel for atopic dermatitisThe first patient has been dosed in the phase two study of PR022 (hypochlorous acid, Realm Therapeutics), a topical gel treatment for patients with atopic dermatitis.
Atopic dermatitis phenotypes may indicate outcomesChildren under two years old with signs of atopic dermatitis have an increased risk of developing asthma and food allergies, researchers report in JAMA Pediatrics. And, young children with both early onset atopic dermatitis and a food allergy, have a “very high risk” of developing asthma or allergic rhinitis.
Patch testing remains underreported
Patch testing remains underreportedPatch testing for allergic contact dermatitis in the pediatric population is performed at a higher rate than previously reported, but still grossly underreported, according to a study of the Pediatric Contact Dermatitis Registry.
Atopic dermatitis associated with different bacteria depending on disease severityNIH investigators find that Staphylococcus epidermidis is predominant in less severe cases, while Staphylococcus aureus is associated with patients who have more severe disease.
Ingredients in eczema topicals pose contact dermatitis riskIngredients used in topical products used to relieve atopic dermatitis in children might put those patients at higher risk for contact dermatitis.
Research suggests new approaches to treat AD
Research suggests new approaches to treat ADResearch aimed at understanding the host-microbial interface in atopic dermatitis is ongoing but already providing insights for novel therapeutic strategies.